Publications

Meddings J, Reichert H, Smith SN, McMahon LF Jr. How do hospital grades publicly displayed on Medicare’s Hospital Compare website compare to whether a hospital was penalized for readmissions and hospital-acquired conditions? Presented at the 2015 Agency for Heathcare Research and Quality (AHRQ) Research Conference, Crystal City, VA, October 4-6, 2015.

Movva N, Babik I, Lobo MA. Effectiveness of the first exoskeletal garment (Playskin LiftTM) to improve reaching and object exploration in infants born with brain injury. Poster presentation at the Northeast Regional IDeA Conference, Bar Harbor, Maine, September 2015.

Kelsh MA, Chia VM. Historical comparator studies: Strengths, limitations, and analytical considerations in using historical pooled clinical data for evaluating efficacy and safety of new therapies. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Boston, MA, August 25, 2015.

Suh M, Mittal L, Hirsch S, Valdes R, Bartlett C, Rohr A, Proctor D. 2015. Lung cancer risk in chromate production workers exposed to hexavalent chromium. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.

Young RR, Thompson CM, Dinesdurage HR, Elbekai RH, Suh M, Rohr AC, Proctor DM. 2015. A robust method for assessing chemically induced mutagenic effects in the oral cavity of transgenic Big Blue® rats. Environ Mol Mutagen 56(7):629-636; doi: 10.1002/em.21951. PMID: 25969955.

Thompson CM, Young RR, Suh M, Dinesdurage HR, Elbekai RH, Harris MA, Rohr AC, Proctor DM. 2015. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats. Environ Mol Mutagen 56(7):621-628; doi: 10.1002/em.21952. PMID: 26010270.

Wu E, Jensen IS, Cyr PL, Fan W, Mitchell M, Sulham K, Nathwani D. Use of oritavancin for the treatment of skin and soft tissue infections: A UK hospital budget impact analysis. ISPOR 20th Annual International Meeting, Philadelphia, PA, 2015.

Jensen I, Halbert R, Giuseppe R, Naoshy S, Iqbal SU, Zhimin X, McSweeney P. 2015. A hospital budget impact model to evaluate plerixafor in stem cell mobilization: Impact of primary research and direct stakeholder engagement. Eur J Hosp Pharm 22(3):142–149; doi: 10.1136/ejhpharm-2014-000543.

Meddings J, Reichert H, Smith S, Iwashyna T, Langa K, Hofer T, McGuirk H, McMahon LF Jr. Functional status, social support and wealth impact readmissions for pneumonia and heart failure beyond standard Medicare risk-adjustors. Academy Health Annual Research Meeting, June 14-15, 2015, Minneapolis, MN.

Sacks NC, Burgess JF, Cabral HJ, McDonnell ME, Pizer SD. 2015. The effects of cost sharing on adherence to medications prescribed for concurrent use: Do definitions matter? J Manag Care Pharmacy 21(8):678–687; doi: 10.18553/jmcp.2015.21.8.678.